pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2

Haifeng Yang, Yoji Andrew Minamishima, Qin Yan, Susanne Schlisio, Benjamin L. Ebert, Xiaoping Zhang, Liang Zhang, William Y. Kim, Aria F. Olumi, William G. Kaelin

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

The VHL tumor suppressor protein (pVHL) is part of an E3 ubiquitin ligase that targets HIF for destruction. pVHL-defective renal carcinoma cells exhibit increased NF-κB activity but the mechanism is unclear. NF-κB affects tumorigenesis and therapeutic resistance in some settings. We found that pVHL associates with the NF-κB agonist Card9 but does not target Card9 for destruction. Instead, pVHL serves as an adaptor that promotes the phosphorylation of the Card9 C terminus by CK2. Elimination of these sites markedly enhanced Card9's ability to activate NF-κB in VHL+/+ cells, and Card9 siRNA normalized NF-κB activity in VHL-/- cells and restored their sensitivity to cytokine-induced apoptosis. Furthermore, downregulation of Card9 in VHL-/- cancer cells reduced their tumorigenic potential. Therefore pVHL can serve as an adaptor for both a ubiquitin conjugating enzyme and a kinase. The latter activity, which promotes Card9 phosphorylation, links pVHL to control of NF-κB activity and tumorigenesis.

Original languageEnglish
Pages (from-to)15-27
Number of pages13
JournalMolecular Cell
Volume28
Issue number1
DOIs
Publication statusPublished - 2007 Oct 12

Fingerprint

Phosphorylation
Von Hippel-Lindau Tumor Suppressor Protein
Carcinogenesis
Ubiquitin-Conjugating Enzymes
Ubiquitin-Protein Ligases
Renal Cell Carcinoma
Small Interfering RNA
Phosphotransferases
Down-Regulation
Apoptosis
Cytokines
Neoplasms
Therapeutics

Keywords

  • CELLCYCLE
  • SIGNALING

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Yang, H., Minamishima, Y. A., Yan, Q., Schlisio, S., Ebert, B. L., Zhang, X., ... Kaelin, W. G. (2007). pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2. Molecular Cell, 28(1), 15-27. https://doi.org/10.1016/j.molcel.2007.09.010

pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2. / Yang, Haifeng; Minamishima, Yoji Andrew; Yan, Qin; Schlisio, Susanne; Ebert, Benjamin L.; Zhang, Xiaoping; Zhang, Liang; Kim, William Y.; Olumi, Aria F.; Kaelin, William G.

In: Molecular Cell, Vol. 28, No. 1, 12.10.2007, p. 15-27.

Research output: Contribution to journalArticle

Yang, H, Minamishima, YA, Yan, Q, Schlisio, S, Ebert, BL, Zhang, X, Zhang, L, Kim, WY, Olumi, AF & Kaelin, WG 2007, 'pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2', Molecular Cell, vol. 28, no. 1, pp. 15-27. https://doi.org/10.1016/j.molcel.2007.09.010
Yang, Haifeng ; Minamishima, Yoji Andrew ; Yan, Qin ; Schlisio, Susanne ; Ebert, Benjamin L. ; Zhang, Xiaoping ; Zhang, Liang ; Kim, William Y. ; Olumi, Aria F. ; Kaelin, William G. / pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2. In: Molecular Cell. 2007 ; Vol. 28, No. 1. pp. 15-27.
@article{d069d9b96c1c4805a90972d0513a4472,
title = "pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2",
abstract = "The VHL tumor suppressor protein (pVHL) is part of an E3 ubiquitin ligase that targets HIF for destruction. pVHL-defective renal carcinoma cells exhibit increased NF-κB activity but the mechanism is unclear. NF-κB affects tumorigenesis and therapeutic resistance in some settings. We found that pVHL associates with the NF-κB agonist Card9 but does not target Card9 for destruction. Instead, pVHL serves as an adaptor that promotes the phosphorylation of the Card9 C terminus by CK2. Elimination of these sites markedly enhanced Card9's ability to activate NF-κB in VHL+/+ cells, and Card9 siRNA normalized NF-κB activity in VHL-/- cells and restored their sensitivity to cytokine-induced apoptosis. Furthermore, downregulation of Card9 in VHL-/- cancer cells reduced their tumorigenic potential. Therefore pVHL can serve as an adaptor for both a ubiquitin conjugating enzyme and a kinase. The latter activity, which promotes Card9 phosphorylation, links pVHL to control of NF-κB activity and tumorigenesis.",
keywords = "CELLCYCLE, SIGNALING",
author = "Haifeng Yang and Minamishima, {Yoji Andrew} and Qin Yan and Susanne Schlisio and Ebert, {Benjamin L.} and Xiaoping Zhang and Liang Zhang and Kim, {William Y.} and Olumi, {Aria F.} and Kaelin, {William G.}",
year = "2007",
month = "10",
day = "12",
doi = "10.1016/j.molcel.2007.09.010",
language = "English",
volume = "28",
pages = "15--27",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2

AU - Yang, Haifeng

AU - Minamishima, Yoji Andrew

AU - Yan, Qin

AU - Schlisio, Susanne

AU - Ebert, Benjamin L.

AU - Zhang, Xiaoping

AU - Zhang, Liang

AU - Kim, William Y.

AU - Olumi, Aria F.

AU - Kaelin, William G.

PY - 2007/10/12

Y1 - 2007/10/12

N2 - The VHL tumor suppressor protein (pVHL) is part of an E3 ubiquitin ligase that targets HIF for destruction. pVHL-defective renal carcinoma cells exhibit increased NF-κB activity but the mechanism is unclear. NF-κB affects tumorigenesis and therapeutic resistance in some settings. We found that pVHL associates with the NF-κB agonist Card9 but does not target Card9 for destruction. Instead, pVHL serves as an adaptor that promotes the phosphorylation of the Card9 C terminus by CK2. Elimination of these sites markedly enhanced Card9's ability to activate NF-κB in VHL+/+ cells, and Card9 siRNA normalized NF-κB activity in VHL-/- cells and restored their sensitivity to cytokine-induced apoptosis. Furthermore, downregulation of Card9 in VHL-/- cancer cells reduced their tumorigenic potential. Therefore pVHL can serve as an adaptor for both a ubiquitin conjugating enzyme and a kinase. The latter activity, which promotes Card9 phosphorylation, links pVHL to control of NF-κB activity and tumorigenesis.

AB - The VHL tumor suppressor protein (pVHL) is part of an E3 ubiquitin ligase that targets HIF for destruction. pVHL-defective renal carcinoma cells exhibit increased NF-κB activity but the mechanism is unclear. NF-κB affects tumorigenesis and therapeutic resistance in some settings. We found that pVHL associates with the NF-κB agonist Card9 but does not target Card9 for destruction. Instead, pVHL serves as an adaptor that promotes the phosphorylation of the Card9 C terminus by CK2. Elimination of these sites markedly enhanced Card9's ability to activate NF-κB in VHL+/+ cells, and Card9 siRNA normalized NF-κB activity in VHL-/- cells and restored their sensitivity to cytokine-induced apoptosis. Furthermore, downregulation of Card9 in VHL-/- cancer cells reduced their tumorigenic potential. Therefore pVHL can serve as an adaptor for both a ubiquitin conjugating enzyme and a kinase. The latter activity, which promotes Card9 phosphorylation, links pVHL to control of NF-κB activity and tumorigenesis.

KW - CELLCYCLE

KW - SIGNALING

UR - http://www.scopus.com/inward/record.url?scp=34948883495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34948883495&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2007.09.010

DO - 10.1016/j.molcel.2007.09.010

M3 - Article

C2 - 17936701

AN - SCOPUS:34948883495

VL - 28

SP - 15

EP - 27

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 1

ER -